Privo Technologies, LLC
Publicly observedPeabody, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Peabody | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Privo Technologies, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | E6ACGUBJMQC5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant14 Jun 2024Publicly observed
NIH SBIR/STTR award: Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer)
USD 1,170,285.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant14 Jun 2024Publicly observed
NIH SBIR/STTR award: Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer)
USD 1,245,681.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.